Graves' disease therapy in children: Truth and inevitable consequences

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 9, 2007, Pages 953-955

  Rivkees, Scott A ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EDITORIAL; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LEUKOPENIA; PEDIATRICS; POSTOPERATIVE COMPLICATION; REMISSION; RISK ASSESSMENT; STEVENS JOHNSON SYNDROME; THYROIDECTOMY; TREATMENT DURATION;

CHILD; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 35648934625     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Pinto T, Salisbury S, Barnes D, Cummings EA. Clinical course of pediatric and adolescent Graves' disease treated with radioactive iodine. J Pediatr Endocrinol Metab 2007; 20: 973-980.
2. Rivkees SA. The treatment of Graves' disease in children. J Pediatr Endocrinol Metab 2006; 19: 1095-1111.
3. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Treatment of Graves' hyperthyroidism with radio-iodine: results of a prospective randomized study. Thyroid 1997; 7: 247-251.
4. Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 2003; 111: 745-749.
5. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 1995; 25: 186-193.
6. Rivkees SA, Sklar C, Freemark M. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83: 3767-3776.
7. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998; 27: 109-126.
8. Radice A, Sinico RA. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005; 38: 93-103.
9. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005; 7: R1072-1081.
10. Cooper DS, Antithyroid drugs. N Engl J Med 2005; 352: 905-917.
11. Weetman AP. Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? Nat Clin Pract Endocrinol Metab 2006; 2: 2-3.
12. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 2000; 85: 3678-3682.
13. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997; 7: 755-760.
14. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997; 82: 1719-1726.
15. Feldt-Rasmussen U, Schleusener H, Carayon P. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab 1994; 78: 98-102.
16. Pognan F. Toxicogenomics applied to predictive and exploratory toxicology for the safety assessment of new chemical entities: a long road with deep potholes. Prog Drug Res 2007; 64: 217, 219-238.
17. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 1974; 38: 976-998.
18. Lee JA, Grumbach MM, Clark OH. The optimal treatment for pediatric Graves' disease is surgery. J Clin Endocrinol Metab 2007; 92: 801-803.
19. Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004; 89: 4229-4233.
20. Rivkees SA, Dinauer C. An optimal treatment for pediatric Graves' disease is radioiodine. J Clin Endocrinol Metab 2007; 92: 797-800.